PT2173710E - Nova forma cristalina - Google Patents
Nova forma cristalina Download PDFInfo
- Publication number
- PT2173710E PT2173710E PT87886545T PT08788654T PT2173710E PT 2173710 E PT2173710 E PT 2173710E PT 87886545 T PT87886545 T PT 87886545T PT 08788654 T PT08788654 T PT 08788654T PT 2173710 E PT2173710 E PT 2173710E
- Authority
- PT
- Portugal
- Prior art keywords
- crystalline form
- novel crystalline
- novel
- crystalline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrrole Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Liquid Crystal Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0715626.8A GB0715626D0 (en) | 2007-08-10 | 2007-08-10 | Crystalline form of zofenopril calcium |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2173710E true PT2173710E (pt) | 2016-01-12 |
Family
ID=38543380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT87886545T PT2173710E (pt) | 2007-08-10 | 2008-08-08 | Nova forma cristalina |
Country Status (14)
Country | Link |
---|---|
US (1) | US8710241B2 (pt) |
EP (1) | EP2173710B1 (pt) |
JP (1) | JP5455905B2 (pt) |
CN (1) | CN101815702B (pt) |
AU (1) | AU2008288295B2 (pt) |
CA (1) | CA2694835C (pt) |
DK (1) | DK2173710T3 (pt) |
ES (1) | ES2556227T3 (pt) |
GB (1) | GB0715626D0 (pt) |
HR (1) | HRP20151166T1 (pt) |
HU (1) | HUE028205T2 (pt) |
PL (1) | PL2173710T3 (pt) |
PT (1) | PT2173710E (pt) |
WO (1) | WO2009022168A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8853421B2 (en) | 2008-02-27 | 2014-10-07 | Generics [Uk] Limited | Crystalline forms of zofenopril calcium |
CA2715726C (en) * | 2008-02-27 | 2014-12-02 | Vinayak Gore | Novel crystalline forms |
SI23949A (sl) | 2011-12-19 | 2013-06-28 | Silverstone Pharma | Nove kristalne soli zofenoprila, postopek za njihovo dobivanje in njihova uporaba v terapiji |
CN104138359B (zh) * | 2013-05-06 | 2016-03-02 | 扬子江药业集团上海海尼药业有限公司 | 佐芬普利钙片的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1144930A (en) | 1978-08-11 | 1983-04-19 | Miguel A. Ondetti | Mercaptoacyl derivatives of substituted prolines |
US4316906A (en) * | 1978-08-11 | 1982-02-23 | E. R. Squibb & Sons, Inc. | Mercaptoacyl derivatives of substituted prolines |
IT1301993B1 (it) * | 1998-08-04 | 2000-07-20 | Menarini Ricerche Spa | Processo per la preparazione di zofenopril sale di calcio. |
WO2005070462A2 (en) * | 2004-01-12 | 2005-08-04 | Sepracor, Inc. | Compositions comprising (s)-amlodipine and an angiotensin receptor blocker and methods of their use |
AU2006264650B2 (en) * | 2005-07-01 | 2012-08-23 | Generics [Uk] Limited | Zofenopril calcium in polymorph form C |
RS53733B1 (en) | 2006-05-26 | 2015-06-30 | Generics | PROCEDURES FOR PREPARATION OF ZOFENOPRIL CALCIUM |
CN101012192A (zh) * | 2007-01-30 | 2007-08-08 | 广东邦民制药厂有限公司 | 一种佐芬普利钙的制备方法 |
-
2007
- 2007-08-10 GB GBGB0715626.8A patent/GB0715626D0/en not_active Ceased
-
2008
- 2008-08-08 PL PL08788654T patent/PL2173710T3/pl unknown
- 2008-08-08 WO PCT/GB2008/050683 patent/WO2009022168A1/en active Application Filing
- 2008-08-08 DK DK08788654.5T patent/DK2173710T3/en active
- 2008-08-08 CA CA2694835A patent/CA2694835C/en not_active Expired - Fee Related
- 2008-08-08 ES ES08788654.5T patent/ES2556227T3/es active Active
- 2008-08-08 CN CN2008801101074A patent/CN101815702B/zh not_active Expired - Fee Related
- 2008-08-08 EP EP08788654.5A patent/EP2173710B1/en not_active Not-in-force
- 2008-08-08 JP JP2010519529A patent/JP5455905B2/ja not_active Expired - Fee Related
- 2008-08-08 HU HUE08788654A patent/HUE028205T2/en unknown
- 2008-08-08 AU AU2008288295A patent/AU2008288295B2/en not_active Ceased
- 2008-08-08 PT PT87886545T patent/PT2173710E/pt unknown
- 2008-08-08 US US12/671,328 patent/US8710241B2/en not_active Expired - Fee Related
-
2015
- 2015-11-02 HR HRP20151166TT patent/HRP20151166T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
EP2173710A1 (en) | 2010-04-14 |
JP5455905B2 (ja) | 2014-03-26 |
ES2556227T3 (es) | 2016-01-14 |
HUE028205T2 (en) | 2016-12-28 |
JP2010535753A (ja) | 2010-11-25 |
EP2173710B1 (en) | 2015-09-16 |
GB0715626D0 (en) | 2007-09-19 |
CN101815702B (zh) | 2012-10-24 |
AU2008288295A1 (en) | 2009-02-19 |
US20110098334A1 (en) | 2011-04-28 |
HRP20151166T1 (hr) | 2016-01-01 |
CA2694835C (en) | 2013-01-29 |
WO2009022168A1 (en) | 2009-02-19 |
CA2694835A1 (en) | 2009-02-19 |
DK2173710T3 (en) | 2015-11-23 |
PL2173710T3 (pl) | 2016-02-29 |
US8710241B2 (en) | 2014-04-29 |
CN101815702A (zh) | 2010-08-25 |
AU2008288295B2 (en) | 2013-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0819182D0 (en) | Crystalline forms | |
EP2152081A4 (en) | NEW CONNECTIONS | |
EP2146745A4 (en) | NOVEL CONNECTIONS | |
GB0705882D0 (en) | Novel compounds | |
GB0706630D0 (en) | Novel compounds | |
GB0705803D0 (en) | Novel compounds | |
EP2128124A4 (en) | NEW HEXATRIENE- -CARBONYL COMPOUND | |
PL2173710T3 (pl) | Nowa postać krystaliczna | |
ZA200806859B (en) | Novel crystalline compounds | |
IL195092A0 (en) | Crystalline form of (s)-1-phenylethylammonium (r)-diphenyl-methanesulphinyl-acetate | |
GB0706772D0 (en) | Novel compound | |
HU0800755D0 (en) | Novel crystalline forms | |
GB0703973D0 (en) | Novel compounds | |
IL213288A0 (en) | Crystalline forms | |
GB0817164D0 (en) | Crystalline forms | |
GB0717332D0 (en) | Novel compound | |
GB0717338D0 (en) | Novel compound | |
GB0717468D0 (en) | Novel compound | |
GB0720917D0 (en) | Novel compound | |
GB0717336D0 (en) | Novel compound | |
GB0717335D0 (en) | Novel compound | |
GB0717334D0 (en) | Novel compound | |
GB0717333D0 (en) | Novel compound | |
GB0710864D0 (en) | Novel compound | |
GB0700991D0 (en) | Novel compounds |